Ucb SA logo

UCB - Ucb SA News Story

€80.94 -0.1  -0.1%

Last Trade - 09/04/21

Sector
Healthcare
Size
Large Cap
Market Cap £13.28bn
Enterprise Value £14.23bn
Revenue £4.64bn
Position in Universe 58th / 848

BRIEF-UCB, Microsoft Expand Drug Development Collaboration

Tue 23rd February, 2021 6:08am
Feb 23 (Reuters) - UCB SA  UCB.BR :
    * UCB AND MICROSOFT EXPAND COLLABORATION TO ACCELERATE DRUG
DISCOVERY AND DEVELOPMENT
    * THROUGH THIS COLLABORATION WITH MICROSOFT, UCB SEEKS TO
DISCOVER
AND DEVELOP MEDICINES FASTER FOR PEOPLE LIVING WITH SEVERE
DISEASES IN IMMUNOLOGY AND NEUROLOGY
    * MICROSOFT WILL PROVIDE AI TECHNOLOGY AND APPLIED
SCIENTISTS TO
WORK ALONGSIDE UCB'S SCIENTISTS AND DATA SPECIALISTS

Source text for Eikon:  ID:nNDL1b1tpL 
Further company coverage:  UCB.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.